Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

CenterPoint Senior Vice President of External Affairs Mike Roeder said the new rate increase will initially start with a $7 ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Now, they're all over ... these medications.” Anjanette Ewen lost 67 pounds on Mounjaro, and credits that weight loss as the reason she found a cancerous lump on her breast. The 50-year-old ...